Skip to main content
logo
Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
55.74
+0.20 (0.36%)
At close: Sep 16, 2026

SHA:688192 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
25,92826,56417,23719,53016,03014,959
Market Cap Growth
-23.06%54.11%-11.74%21.83%7.16%-
Enterprise Value
25,54725,70417,34218,89114,51814,805
Last Close Price
55.7457.6041.4747.8539.3737.01

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
26.7633.1647.89213.94-1454.37
PB Ratio
22.9620.5086.1623.019.126.07
P/TBV Ratio
34.5729.60-50.5112.667.53

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
26.3732.0848.18206.94-1439.37

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.200.965.790.480.050.04
Net Debt / Equity Ratio
-0.34-0.541.59-0.40-0.76-0.81
Net Debt / EBITDA Ratio
0.630.90-0.340.301.773.12
Net Debt / FCF Ratio
0.540.92-0.400.341.973.97
Asset Turnover
0.320.340.220.05-0.01
Inventory Turnover
0.950.840.280.54--
Quick Ratio
2.492.111.111.785.709.82
Current Ratio
2.632.221.272.035.939.96
Return on Equity (ROE)
-43.70%-102.76%-179.21%-84.98%-34.87%-37.83%
Return on Assets (ROA)
-13.68%-21.71%-37.81%-40.35%-20.52%-21.46%
Return on Capital Employed (ROCE)
-32.20%-40.60%-104.20%-110.20%-43.20%-26.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.30%-2.88%-4.91%-5.67%-4.59%-4.48%
FCF Yield
-2.71%-2.86%-4.57%-5.12%-4.22%-3.35%
Buyback Yield / Dilution
-9.39%-7.75%-1.83%-0.70%-12.29%-0.07%